NASDAQ:CLDX   Celldex Therapeutics, Inc.
Good time to enter CLDX!
(1) rising trendline
(2) Zacks Rank #2 = buy (short-term for next 1-3 months)
(3) Zacks ABR (5 brokers) = 1.80 (almost strong buy); past brokers' recommendations = 2 holds, 3 buys, 0 strong buy, 0 sell, 0 strong sell
(4) Zacks' Average Target Price = $6.63 (more than double current price of $3.03)
(5) Risk-Reward ratio = 1:1+

Let me know what you think! Peace
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.